(Q47272996)

13 January 2018

title

Changes in facial fat in HIV-related lipoatrophy, wasting, and weight gain measured by magnetic resonance imaging (English)

1 reference

13 January 2018

1 reference

1 reference

Nicholas I Paton

1

1 reference

13 January 2018

Yong Yang

series ordinal

2

1 reference

13 January 2018

Naing Oo Tha

series ordinal

3

1 reference

13 January 2018

Yih-Yian Sitoh

series ordinal

4

1 reference

13 January 2018

publication date

1 July 2007

1 reference

13 January 2018

published in

HIV Clinical Trials

1 reference

13 January 2018

volume

8

1 reference

13 January 2018

issue

4

1 reference

13 January 2018

page(s)

227-234

1 reference

13 January 2018

describes a project that uses

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

cites work

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

1 reference

https://api.crossref.org/works/10.1310%2FHCT0804-227

Changes in body fat measured by DEXA in patients taking different formulations of stavudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0804-227

Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0804-227

Fat distribution in men with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0804-227

Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0804-227

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0804-227

Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0804-227

A 48-week, randomized, open-label comparison of three abacavir-based substitution approaches in the management of dyslipidemia and peripheral lipoatrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0804-227

Longitudinal changes in body composition measured with a variety of methods in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0804-227

21 January 2018

Identifiers

DOI

10.1310/HCT0804-227

1 reference

13 January 2018

1 reference

13 January 2018